Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oncology Indications Can Be Cellular Targets Rather Than Organs, FDA Says

Executive Summary

Cancer therapies can be indicated for tumors defined by cellular markers rather than conventional organ-specific targets, FDA Oncology Drug Products Division Director Richard Pazdur, MD, said during the American Society of Clinical Oncology annual meeting in New Orleans June 5

You may also be interested in...



Cancer Drugs Will Follow AIDS “Cocktail” Model, ASCO Researchers Say

Cancer treatment will start following the HIV "cocktail" model, researchers said at the American Society of Clinical Oncology annual meeting in New Orleans

Cancer Drugs Will Follow AIDS “Cocktail” Model, ASCO Researchers Say

Cancer treatment will start following the HIV "cocktail" model, researchers said at the American Society of Clinical Oncology annual meeting in New Orleans

Colorectal Cancer Drug Costs May Force Rationing – ASCO Presentation

Up-front spending on pharmaceuticals to treat colorectal cancer in the U.S. would be $7.5 bil. per year if oncologists use newly launched therapies without restrictions, Memorial-Sloan Kettering Cancer Center researcher Leonard Saltz, MD, told the American Society of Clinical Oncology annual meeting June 5 in New Orleans

Related Content

UsernamePublicRestriction

Register

PS044163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel